BIVI vs BLTE

BioVie Inc. vs Belite Bio, Inc — Valuation Comparison 2026

BIVI

Biotechnology
BioVie Inc.
Quality
3.2
out of 10
Value Trap
36
LOW
Price
$1.44
Last close
Models
7/13
Active
VS

BLTE

Biotechnology
Belite Bio, Inc
Quality
4.7
out of 10
Value Trap
24
SAFE
Price
$148.00
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType BIVI Fair ValueBIVI Upside BLTE Fair ValueBLTE Upside
Bayesian DCF Intrinsic $1.46 +1.2% $49.41 -66.6%
Earnings Power Value Intrinsic $77.24 -52.1%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.27 -84.1% $7.86 -94.7%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for BIVI vs BLTE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BIVI vs BLTE — Which Stock Is More Undervalued?

BLTE scores higher with a 4.7/10 quality rating vs BIVI's 3.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing BioVie Inc. (BIVI) and Belite Bio, Inc (BLTE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BIVI currently trades at $1.44 with a QOC of 3.2/10, while BLTE trades at $148.00 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).